We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EL:NYSEEstee Lauder Companies, Inc. (The) Analysis

Data as of 2026-05-24 - not real-time

$88.32

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Estee Lauder’s stock is trading at $88.32, substantially above the DCF‑derived fair value of $62.15, implying an overvalued position despite an 8% upside/downside metric that hints at modest near‑term upside. The technical picture is mixed: the 20‑day SMA (81.05) sits below the current price, the 50‑day SMA (78.11) is also below, but the 200‑day SMA (93.54) remains above, signaling a neutral to slightly bearish long‑term trend. Momentum indicators are bullish – MACD histogram is positive and the signal line is bullish – yet RSI is at 62.9, edging into overbought territory, and volume is on a decreasing trend, suggesting waning buying pressure. On the fundamentals side, Q3 2026 delivered a 40% EPS beat (forward EPS $3.18) and margin expansion, but the trailing profit margin is still negative (‑1.7%) and ROE is –5.9%, reflecting ongoing profitability challenges. The company carries a very high debt‑to‑equity ratio of 233, a payout ratio of 471%, and a beta of 1.74, all of which amplify financial and market risk. While the brand portfolio remains strong and the dividend yield is 1.59%, the unsustainable payout and elevated leverage temper the attractiveness of the stock.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD but price below 200‑day SMA
  • Recent EPS beat and margin expansion
  • Decreasing volume and elevated beta

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • High valuation multiples versus modest revenue growth
  • Heavy debt load and negative ROE
  • Unsustainable dividend payout ratio

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Significant overvaluation relative to DCF fair value
  • Persistent leverage and weak profitability metrics
  • Elevated volatility and market risk in consumer discretionary space

Key Metrics & Analysis

Financial Health

Revenue Growth4.60%
Profit Margin-1.67%
P/E Ratio27.8
ROE-5.95%
ROA4.87%
Debt/Equity232.91
P/B Ratio8.0
Op. Cash Flow$1.8B
Free Cash Flow$1.8B

Technical Analysis

TrendNeutral
RSI62.9
Support$75.22
Resistance$90.57
MA 20$81.05
MA 50$78.11
MA 200$93.54
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value$62.15
Target Price$95.43
Upside/Downside8.06%
GradeOvervalued
TypeGrowth
Dividend Yield1.59%

Risk Assessment

Beta1.74
Volatility48.19%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.